PULM Pulmatrix, Inc.

0  -2%
Previous Close 2.89
Open 2.91
Price To book 4.90
Market Cap 50.74M
Shares 17,929,000
Volume 320,078
Short Ratio 0.81
Av. Daily Volume 4,360,630

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data due 4Q 2017.

Latest News

  1. Today's Research Reports on Biotech Stocks to Watch: TherapeuticsMD and Pulmatrix
  2. Q1 Roundup: Winners and Losers of Biotech Sector
  3. Pulmatrix Adds Two Top Fungal Infection Experts to its Scientific Advisory Board
  4. Today's Research Reports on Stocks to Watch: Pulmatrix and Aevi Genomic Medicine
  5. Pulmatrix Inhaled Drug Delivery Tech Gets EU Patent
  6. Why Pulmatrix Investors Are Breathing a Sigh of Relief
  7. Pulmatrix Receives European Patent for its Inhaled Drug Delivery Technology
  8. Pulmatrix, Inc. :PULM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 16, 2017
  9. Pulmatrix Reports 2016 Financial Results; Provides 2017 Outlook on Pulmonary Disease Pipeline
  10. Explaining Innovative Drug Technologies Through Animation
  11. Penny Stocks to Watch for March 2017 (MOBL)
  12. Biotech's Rally Continues to Build in 2017: Today's Reports on Achillion Pharmaceuticals and Pulmatrix
  13. Harvard Scientist Points to Pulmatrix's Inhaled Drug Delivery Innovation to Help Fight Lung Disease
  14. Pulmatrix Announces $3.33M Registered Direct Issue
  15. CORRECTION: Press Release Titled - "Are Pulmatrix Shares Taking Investors' Breath Away or Just Hot Air"
  16. Biotech Premarket Movers: PharmAthene, Earth Science Tech, Pulmatrix
  17. Are Pulmatrix Shares Taking Investors' Breath Away or Just Hot Air
  18. Pulmatrix Announces Over $3.0 Million Registered Direct Offering
  19. Hopes for Tax Reform, Less Regulation Lift Indices
  20. Shark Bites: Fed? What Fed?